275 related articles for article (PubMed ID: 18346273)
21. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
22. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.
Crotti TN; Dharmapatni AA; Alias E; Zannettino AC; Smith MD; Haynes DR
Arthritis Res Ther; 2012 Nov; 14(6):R245. PubMed ID: 23146195
[TBL] [Abstract][Full Text] [Related]
23. Relative expression and correlation of tumor necrosis factor-α, interferon-γ, and interleukin-17 in the rheumatoid synovium.
Nakajima A; Aoki Y; Sonobe M; Watanabe F; Takahashi H; Saito M; Nakagawa K
Clin Rheumatol; 2016 Jul; 35(7):1691-7. PubMed ID: 27038187
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis.
Dolhain RJ; Tak PP; Dijkmans BA; De Kuiper P; Breedveld FC; Miltenburg AM
Br J Rheumatol; 1998 May; 37(5):502-8. PubMed ID: 9651076
[TBL] [Abstract][Full Text] [Related]
25. Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment.
van Baarsen LG; Wijbrandts CA; Rustenburg F; Cantaert T; van der Pouw Kraan TC; Baeten DL; Dijkmans BA; Tak PP; Verweij CL
Arthritis Res Ther; 2010; 12(1):R11. PubMed ID: 20096109
[TBL] [Abstract][Full Text] [Related]
26. [Role of anti-TNF therapy in rheumatoid arthritis].
Meyer O
Presse Med; 2000 Mar; 29(9):463-8. PubMed ID: 10745935
[TBL] [Abstract][Full Text] [Related]
27. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.
Kane D; Gogarty M; O'leary J; Silva I; Bermingham N; Bresnihan B; Fitzgerald O
Arthritis Rheum; 2004 Oct; 50(10):3286-95. PubMed ID: 15476228
[TBL] [Abstract][Full Text] [Related]
28. Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis.
Klaasen R; Wijbrandts CA; van Kuijk AW; Pots D; Gerlag DM; Tak PP
Ann Rheum Dis; 2012 Jul; 71(7):1260-1. PubMed ID: 22345123
[No Abstract] [Full Text] [Related]
29. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
[TBL] [Abstract][Full Text] [Related]
30. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
31. Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
Ulfgren AK; Andersson U; Engström M; Klareskog L; Maini RN; Taylor PC
Arthritis Rheum; 2000 Nov; 43(11):2391-6. PubMed ID: 11083259
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression.
Li YB; Xu P; Xu K; Cai YS; Sun MY; Yang L; Sun J; Lu SM
Mol Cell Biochem; 2016 Sep; 420(1-2):161-70. PubMed ID: 27522665
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
34. Scoring evaluation for histopathological features of synovium in patients with rheumatoid arthritis during anti-tumor necrosis factor therapy.
Yamanaka H; Goto K; Miyamoto K
Rheumatol Int; 2010 Jan; 30(3):409-13. PubMed ID: 19826823
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
Niki Y; Takeuchi T; Nakayama M; Nagasawa H; Kurasawa T; Yamada H; Toyama Y; Miyamoto T
PLoS One; 2012; 7(5):e37447. PubMed ID: 22629396
[TBL] [Abstract][Full Text] [Related]
36. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
[TBL] [Abstract][Full Text] [Related]
37. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
[TBL] [Abstract][Full Text] [Related]
38. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Unzueta MT; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
Clin Exp Rheumatol; 2006; 24(4):373-9. PubMed ID: 16956426
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients peripheral blood mononuclear cells stimulated with lipopolysaccharide].
Fabris M; Tolusso B; Gremese E; Tomietto P; Ferraccioli G
Reumatismo; 2004; 56(2):94-103. PubMed ID: 15309217
[TBL] [Abstract][Full Text] [Related]
40. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.
Heinhuis B; Koenders MI; van Riel PL; van de Loo FA; Dinarello CA; Netea MG; van den Berg WB; Joosten LA
Ann Rheum Dis; 2011 Apr; 70(4):660-7. PubMed ID: 21187297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
